Yes. Emmes EVA devices are FDA-regulated Class I 510(k)-exempt devices; Emmes is listed with the FDA as a medical device manufacture.

Emmes EVA devices are CE Marked and are cleared for marketing in the UK.  Connect With Us:  Please reach out to us and let us know your research plans so we can prioritize our regulatory compliance agenda.

Yes. In fact, Emmes EVA offers higher testing consistency compared to chart-based visual acuity assessment as mistakes in protocol conduction and data scoring/handling are mitigated via semi-automated control; making Emmes EVA devices an ideal visual acuity assessment tool.

Yes. All Emmes EVA devices report consistent visual acuity results across all models, whether new or legacy.

The EVA device requires from the purchaser: power to operate, accommodations for a 3-meter eye-to-screen testing lane, and accommodations to bring line-of-sight parallel to the ground (e.g. a height-adjustable table for the EVA device and/or a height-adjustable chair for subjects).